The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Celgene; Lilly; MSD; Novartis; Pfizer; Roche; Somatex
Travel, Accommodations, Expenses - Celgene; Novartis; Pfizer
Multiomic factor analysis for pathologic complete response (pCR) after 12 weeks of pembrolizumab + trastuzumab + pertuzumab in HER2-enriched (HER2-E) early breast cancer (eBC) in the Keyriched-1 trial.
 
Monika Karla Graeser
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca
 
Oleg Gluz
Honoraria - AstraZeneca; Celgene; Genomic Health/Exact Sciences; NanoString Technologies; Novartis; Pfizer; Roche
Consulting or Advisory Role - Celgene; Genomic Health/Exact Sciences; Gilead Sciences; Lilly; Molecular health; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Expert Testimony - Genomic Health
Travel, Accommodations, Expenses - Roche
 
Peter Schmid
Employment - Roche (I)
Honoraria - AstraZeneca; Bayer; Bayer; Boehringer Ingelheim; Celgene; Celgene; Eisai; Genentech (Inst); Gilead Sciences Hong Kong; Merck; Novartis; Oncogenex (Inst); Oncogenex (Inst); Pfizer; Puma Biotechnology; Roche; Sanofi; Stemline Therapeutics
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Celgene; Eisai; Genentech/Roche (I); Merck; Novartis; Pfizer; Puma Biotechnology
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Genentech (Inst); Medivation; Novartis (Inst); Oncogenex (Inst); Roche (Inst)
Travel, Accommodations, Expenses - ESMO; SABS
 
Katarzyna Jozwiak
No Relationships to Disclose
 
Friedrich Feuerhake
No Relationships to Disclose
 
Valery Volk
No Relationships to Disclose
 
Daniel Ulbrich-Gebauer
No Relationships to Disclose
 
Claudia Biehl
No Relationships to Disclose
 
Mattea Reinisch
No Relationships to Disclose
 
Kerstin Luedtke-Heckenkamp
No Relationships to Disclose
 
Andreas D. Hartkopf
Honoraria - Agendia; Amgen; AstraZeneca; Clovis Oncology; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Hexal; Lilly; MSD; Novartis; Onkowissen; Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - Agendia; Amgen; AstraZeneca; Clovis Oncology; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Hexal; Lilly; MSD; Novartis; Onkowissen; Pfizer; Pierre Fabre; Roche; Seagen
Speakers' Bureau - AstraZeneca; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
Research Funding - Exact Sciences
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Pfizer; Roche
 
Felix Hilpert
No Relationships to Disclose
 
Michael Braun
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Exact Sciences; Gilead Sciences; Novartis; Pfizer
Speakers' Bureau - Exact Sciences; Novartis
 
Jens U. Blohmer
No Relationships to Disclose
 
Matthias Christgen
No Relationships to Disclose
 
Hans Heinrich Kreipe
No Relationships to Disclose
 
Ulrike Nitz
Honoraria - Agendia; Amgen; Celgene; Genomic Health; NanoString Technologies; Novartis; Pfizer; Roche; Teva
Consulting or Advisory Role - Genomic Health; Roche; Seagen
Research Funding - Agendia (Inst); Amgen (Inst); Celgene (Inst); Genomic Health (Inst); NanoString Technologies (Inst); Roche (Inst); Sanofi (Inst)
Expert Testimony - Genomic Health
Travel, Accommodations, Expenses - Genomic Health; Pfizer; Roche
 
Enrico Pelz
No Relationships to Disclose
 
Nadia Harbeck
Stock and Other Ownership Interests - West German Study Group
Honoraria - AstraZeneca; Daiichi-Sankyo; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Seagen; Viatris; Zuelligpharma
Consulting or Advisory Role - Gilead Sciences; Roche/Genentech; Seagen; West German Study Group (I)
Speakers' Bureau - EPG Communication; Medscape; Springer Healthcare
Research Funding - AstraZeneca (Inst); Lilly (Inst); MSD (Inst); Roche/Genentech (Inst)
 
Sherko Kuemmel
Consulting or Advisory Role - Agendia; Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Exact Sciences; Gilead Sciences; Hologic; Lilly; MSD Oncology; Novartis; Pfizer; pfm medical; PINK; Roche/Genentech; Seagen; SOMATEX; Sonoscape; Stryker
Travel, Accommodations, Expenses - Daiichi Sankyo; Gilead Sciences; Roche
(OPTIONAL) Uncompensated Relationships - West German Study Group